Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-028685
Filing Date
2025-09-09
Accepted
2025-09-09 16:14:01
Documents
1
Period of Report
2025-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7159
  Complete submission text file 0001437749-25-028685.txt   8885
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMUNON, INC.. 997 LENOX DRIVE, SUITE 100 LAWRENCEVILLE NJ 08648
Business Address
Lindborg Stacy (Reporting) CIK: 0001813667 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 251303312